Phase I trial and tumour localisation of the anti-EGFR monoclonal antibody ICR62 in head and neck or lung cancer
- 1 January 1996
- journal article
- clinical trial
- Published by Springer Nature in British Journal of Cancer
- Vol. 73 (2), 228-235
- https://doi.org/10.1038/bjc.1996.40
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- The Binding of HB-EGF to Tumor Cells Is Blocked by mAbs Which Act as EGF and TGFα AntagonistsBiochemical and Biophysical Research Communications, 1995
- Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinomaThe Lancet, 1994
- Immunotherapy with antibodies to the EGF receptorInternational Journal of Cancer, 1994
- Betacellulin: a mitogen from pancreatic beta cell tumorsScience, 1993
- Cancer Progression and Growth: Relationship of Paracrine and Autocrine Growth Mechanisms to Organ Preference of MetastasisExperimental Cell Research, 1993
- Malignant astrocytomas treated with iodine-125 labeled monoclonal antibody 425 against epidermal growth factor receptor: A phase II trialInternational Journal of Radiation Oncology*Biology*Physics, 1992
- Structure and Function of Human Amphiregulin: A Member of the Epidermal Growth Factor FamilyScience, 1989
- Radioimmunoscintigraphy of squamous carcinomas of the head and neckHead & Neck Surgery, 1987
- RECEPTORS FOR EPIDERMAL GROWTH FACTOR AND OTHER POLYPEPTIDE MITOGENSAnnual Review of Biochemistry, 1987
- Autocrine growth factors and cancerNature, 1985